Award

Regulation of ventricular remodeling by a circular RNA circ-Slc8a1

Description: Heart diseases are the leading cause of death in developed countries. Over time, as hearts age or become senescent, adverse remodelling that is initially beneficial, progressively leads to reduced heart functioning. Our research aims to understand the molecular mechanisms that underlie this remodeling and repair. Circular RNAs are closed continuous loops of RNA that were recently detected in eukaryotic cells, and may affect cell physiology through a variety of mechanisms. Our RNA sequencing results revealed that the circular RNA circSlc8A1 is tightly associated with heart diseases. We hypothesize that circular RNAs may regulate cellular ageing and tissue repair by binding to protein regulators of heart fibrosis. To test this, we will modify the two cell types in the heart, namely cardiomyocytes and cardiac fibroblasts, so that they express more of the circular RNAs in question. We can also use the reverse approach to silence circular RNA expression, and observe the changes in function. Using these approaches, in conjunction with standard experimental models, we can better understand the function of circular RNAs in heart diseases. There are two unique aspects to our proposed study. Firstly, we are among the first to produce a stable expression system allowing long-term studies. The second unique approach is our inhibitor system that is designed to block the function of individual circular RNAs in cell and animal models. These allow us to specifically study individual circular RNAs, and better understand any causal relationships. Our proposed experiments will help us explore the regulatory roles of circular RNAs in both heart aging and other cellular repair contexts. The agents developed may be used as tools in understanding the role of circular RNAs in heart development, aging, disease-associated injury and tissue regeneration. With these approaches, we hope to design therapies to intervene against the adverse remodeling associated with age-related heart disease.
Amount: CA$945,000
Funding type: research
Funder scheme: Project Grant
Start date: 2019-10-01
End date: 2024-09-30
Investigator: Burton Yang
Institution: Sunnybrook Health Sciences Centre (Toronto, Ontario)
Funded outputs count: 16
Funder award ID: 166107_1
OpenAlex ID: G5332597828
2025 · Feiya Li, William Weidong Du, et al. · Cardiovascular Research · 9
2023 · William W. Du, Javeria Qadir, et al. · Advanced Science · 17
2022 · Kevin Y. Du, Javeria Qadir, et al. · Cancers · 5
2022 · Shuo-yang Wen, Javeria Qadir, et al. · Trends in Molecular Medicine · 142
2022 · Jindong Xu, William W. Du, et al. · Molecular Therapy — Nucleic Acids · 50
2022 · Sema Misir, Nan Wu, et al. · Cell Death and Differentiation · 470
2022 · Javeria Qadir, Feiya Li, et al. · Theranostics · 23
2021 · William W. Du, Jindong Xu, et al. · Circulation Research · 91
2021 · Feiya Li, Burton B. Yang · Frontiers in Oncology · 3
2021 · Alina T. He, Jinglei Liu, et al. · Signal Transduction and Targeted Therapy · 549
2021 · Qiwei Yang, Feiya Li, et al. · Molecular Therapy · 167
2020 · Feiya Li, Qiwei Yang, et al. · Seminars in Cancer Biology · 130
Year
Topic